Gene Expression Analysis during Platelet-Like Particle Production in Phorbol Myristate Acetate-Treated MEG-01 Cells(Molecular and Cell Biology)

    • ISAKARI Yoshimasa
    • Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima:Molecular Medical Science Institute, Otsuka Pharmaceutical Co., Ltd.
    • SOGO Shinji
    • Molecular Medical Science Institute, Otsuka Pharmaceutical Co., Ltd.
    • ISHIDA Tatsuhiro
    • Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima
    • KAWAKAMI Takuma
    • Molecular Medical Science Institute, Otsuka Pharmaceutical Co., Ltd.

    • TAKI Takao
    • Molecular Medical Science Institute, Otsuka Pharmaceutical Co., Ltd.
    • KIWADA Hiroshi
    • Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima

Abstract

A comprehensive gene-expression analysis during platelet (PLT) production from megakaryocytes may give important information on genes involved in the PLT production process. However, the low abundance of primary megakaryocytes makes the gene expression analysis difficult. Therefore, we employed MEG-01 cells, a human megakaryocytic cell line, and confirmed that the cell line produces PLT-like particles by treatment with phorbol myristate acetate (PMA). After treatment of MEG-01 cells with PMA for 8 or 24h, comprehensive gene expression analysis was carried out using a microarray and Reverse Transcription-Polymerase Chain Reaction (RT-PCR). From the microarray analysis, 141 genes were up-regulated (>2-fold) and 164 genes were down-regulated (<1/2-fold). However, known PLT-related genes were not included in the up- or down-regulated genes. On the other hand, RT-PCR analysis detected increased expression of β1-tubulin, CD62P, gpIbα and gpIII, which are related to PLT function and megakaryocyte differentiation, following PMA treatment for 24h. These results indicate that the MEG-01 cell may be an alternative model system to study the process of human PLT production from megakaryocytes. The gene-expression analysis might be a powerful tool for identifying genes related to PLT production, if the experimental conditions are optimized.

Journal

Biological & pharmaceutical bulletin   [List of Volumes]

Biological & pharmaceutical bulletin 32(3), 354-358, 2009-03-01  [Table of Contents]

The Pharmaceutical Society of Japan

References:  23

You must have a user ID to see the references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Preview

Preview

Codes

  • NII Article ID (NAID) :
    110007122743
  • NII NACSIS-CAT ID (NCID) :
    AA10885497
  • Text Lang :
    ENG
  • Article Type :
    ART
  • ISSN :
    09186158
  • NDL Article ID :
    10166209
  • NDL Source Classification :
    ZS51(科学技術--薬学)
  • NDL Call No. :
    Z53-V41
  • Databases :
    CJP  NDL  NII-ELS  J-STAGE